Reporting Organization: | Elizabeth Glaser Pediatric AIDS Foundation |
---|---|
Total Budget ($CAD): | $ 10,000,000 |
Timeframe: | March 20, 2012 - March 31, 2017 |
Status: | Completion |
Contact Information: | Unspecified |
Elizabeth Glaser Pediatric AIDS Foundation
Uganda - $ 3,334,000.00 (33.34%) | |
|
|
Eswatini - $ 3,333,000.00 (33.33%) | |
|
|
Zimbabwe - $ 3,333,000.00 (33.33%) | |
|
Sexual Health & Rights (67 %) | |
|
|
HIV (33 %) | |
|
This project, which is part of the renewed Canadian HIV Vaccine Initiative (CHVI), aims to improve country progress towards the elimination of pediatric HIV by identifying community-based interventions with the most potential to scale up prevention of mother-to-child transmission of HIV (PMTCT) and maternal-newborn-child health (MNCH) services in sub-Saharan Africa. These interventions aim to increase demand, uptake and retention of services. The focus on PMTCT under CHVI addresses the immediate prevention needs of those most at risk while researchers pursue a safe and effective vaccine.
Gender and age: | Unspecified |
---|---|
Total Direct Population: | Unspecified |
Unspecified
Return to topThe expected intermediate outcomes for this project include: increased uptake and demand for maternal newborn and child health and prevention of mother-to-child transmission of HIV (MNCH/PMTCT) services in targeted communities; increased retention MNCH/PMTCT services; and increased number of couples with joint decision-making about sexual behaviours and participation in PMTCT programs.
Results achieved as of May 2013 include: Start-up activities of the program were completed, including: staff were recruited and vehicles were purchased; implementation resources were developed, such as standard operating procedures, training manuals, and participant manuals, as well as information, education and communications materials. The approval to carry out the formative and baseline research was received from all three program countries: Uganda, Zimbabwe, and Swaziland.